Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a major clinical trial. CNN values your feedback 1.

Vagus nerve stimulation has generally been used to treat epilepsy. The U.S. Food and Drug Administration (FDA) approved VNS in 2005 as an option for people with treatment-resistant depression.

A vagus nerve stimulation device was approved by the Food and Drug Administration (FDA) nearly two decades ago for treatment-resistant depression, but it has not become widely available.

A landmark study has found that adjunctive vagus nerve stimulation (VNS) significantly improves treatment-resistant depression outcomes over a 5-year period. These findings were published July 1 ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a major clinical trial. CNN values your feedback 1.

Vagus nerve stimulation can also increase the release of important brain chemicals such as serotonin and norepinephrine, ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a major clinical trial.